Cargando…

Remdesivir for COVID-19: challenges of underpowered studies

Detalles Bibliográficos
Autor principal:	Norrie, John David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190306/ https://www.ncbi.nlm.nih.gov/pubmed/32423580 http://dx.doi.org/10.1016/S0140-6736(20)31023-0

Ejemplares similares

The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021)

Remdesivir for COVID-19 in Europe: will it provide value for money?
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

COVID-19: underpowered randomised trials, or no randomised trials?
por: Fretheim, Atle
Publicado: (2021)

PRINCIPLE: a community-based COVID-19 platform trial
por: Macleod, John, et al.
Publicado: (2021)

Unethical Conduct of Underpowered Clinical Trials
por: Habibzadeh, Farrokh
Publicado: (2013)

Underpowered samples, false negatives, and unconscious learning
por: Vadillo, Miguel A., et al.
Publicado: (2015)

Awake prone positioning in COVID-19: is tummy time ready for prime time?
por: Weatherald, Jason, et al.
Publicado: (2021)

Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

237 Studies of epilepsy surgery outcomes are statistically underpowered.
por: Dickey, Adam, et al.
Publicado: (2022)

Remdesivir saves lives. Were 3 years needed to learn that?
por: Kalil, Andre C
Publicado: (2023)

Current Incentives for Scientists Lead to Underpowered Studies with Erroneous Conclusions
por: Higginson, Andrew D., et al.
Publicado: (2016)

Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
por: Haber, Noah A., et al.
Publicado: (2021)

Underpowered trials in critical care medicine: how to deal with them?
por: Roozenbeek, Bob, et al.
Publicado: (2010)

Targeting Next Generations to Change the Common Practice of Underpowered Research
por: Crutzen, Rik, et al.
Publicado: (2017)

The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews
por: Turner, Rebecca M., et al.
Publicado: (2013)

COVID-19 vaccines: modes of immune activation and future challenges
por: Teijaro, John R., et al.
Publicado: (2021)

Handover of patients: the challenges of COVID-19
por: Wasserteil, Netanel, et al.
Publicado: (2020)

Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
por: Haber, Noah A., et al.
Publicado: (2021)

Underpowered observational studies create confusion regarding clinical impact of surgical interventions
por: Gupta, Saurabh, et al.
Publicado: (2019)

COVID-19 and involuntary hospitalisation: navigating the challenge
por: Gold, Azgad, et al.
Publicado: (2020)

Liver injury in COVID-19: management and challenges
por: Zhang, Chao, et al.
Publicado: (2020)

Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Addressing the public mental health challenge of COVID-19
por: Campion, Jonathan, et al.
Publicado: (2020)

COVID-19 vaccines: early success and remaining challenges
por: Bar-Zeev, Naor, et al.
Publicado: (2020)

COVID-19: a new challenge for human beings
por: Yang, Penghui, et al.
Publicado: (2020)

COVID-19 vaccines for the European region: an unprecedented challenge
por: Kluge, Hans, et al.
Publicado: (2021)

Challenges and opportunities to end tuberculosis in the COVID-19 era
por: Wingfield, Tom, et al.
Publicado: (2021)

Data journalism and the COVID-19 pandemic: opportunities and challenges
por: Desai, Angel, et al.
Publicado: (2021)

Addressing challenges to rolling out COVID-19 vaccines in African countries
por: Nachega, Jean B, et al.
Publicado: (2021)

Concordance of deregulated mechanisms unveiled in underpowered experiments: PTBP1 knockdown case study
por: Gardeux, Vincent, et al.
Publicado: (2014)

Response to Underpowered Observational Studies Create Confusion Regarding Clinical Impact of Surgical Interventions
por: Johnsrud, Daniel O., et al.
Publicado: (2019)

Challenges in the interpretation and application of typical imaging features of COVID-19
por: Hammer, Mark M, et al.
Publicado: (2020)

Challenges in lung cancer therapy during the COVID-19 pandemic
por: Calabrò, Luana, et al.
Publicado: (2020)

India's COVID-19 vaccination drive: key challenges and resolutions
por: Choudhary, Om Prakash, et al.
Publicado: (2021)

COVID-19 in Europe: new challenges for addressing vaccine hesitancy
por: Karafillakis, Emilie, et al.
Publicado: (2022)

Adapted vaccine strategy: facing the persistent challenges of COVID-19
por: Shang, Lianhan, et al.
Publicado: (2023)

Rapid COVID-19 vaccine rollout: immense success but challenges ahead
por: Sandmann, Frank G, et al.
Publicado: (2022)

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022)

COVID-19, vaccine hesitancy and child vaccination: Challenges from Brazil
por: Fernandez, Michelle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7cq11v1lgqg6uan57g206jrm1i